|
|
| Research article summary (published 30 Oct 2003): |
Corticobasal degeneration as a cognitive disorder.
Full Abstract
The presence of cognitive impairment in corticobasal degeneration (CBD) is now widely recognised. Our review of the literature reveals that, although the pattern and severity of neuropsychological impairments can be highly variable across patients, several general trends can be identified. The most characteristic impairments are limb apraxia (usually ideomotor), constructional and visuospatial difficulties, acalculia, frontal dysfunction, and nonfluent aphasia. The limb apraxia is associated with deficits in drawing, copying, and handwriting, but there is emerging evidence that the problems with handwriting are not due exclusively to the apraxia. The findings with respect to episodic memory are more variable, but when there is impairment in this area, it tends to be milder than that seen in Alzheimer's disease. Semantic memory functioning appears relatively preserved but has been poorly studied. Problems with speech are common, and may be due to dysarthria or buccofacial apraxia. Aphasia, although initially considered rare, is in fact a common accompaniment of CBD, may be the presenting feature, and is typically nonfluent in type. More systematic investigation of the clinical and neuropathological overlap between progressive nonfluent aphasia (generally considered to be a form of frontotemporal dementia) and CBD is needed.
Author information
Author/s: Graham, Naida L (NL); Bak, Thomas H (TH); Hodges, John R (JR);
Affiliation: University Neurology Unit, University of Cambridge, Cambridge, United Kingdom.
Journal and publication information
Publication Type: Journal Article; Review
Journal: Movement disorders : official journal of the Movement Disorder Society (Mov Disord), published in United States. (Language: eng)
Reference: 2003-Nov; vol 18 (issue 11) : pp 1224-32
Dates: Created 2003/11/25; Completed 2004/03/25; Revised 2004/11/17;
PMID: 14639661, status: MEDLINE (last retrieved date: 2/18/2009)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MeSH Headings (categories) shown below.
Note: Bold headings indicate primary MeSH headings or qualifiers.
Associated Chemicals: tau Proteins (0)Related articles
These are the most related articles currently in our database:
- Corticobasal syndrome with novel argyrophilic glial inclusions.
29 Apr 2005 - Focal cortical atrophy syndromes.
29 Jun 1996 - Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms.
27 Feb 1999 - Comprehension of before and after in frontotemporal degeneration.
30 Dec 2004 - Apraxia differs in corticobasal degeneration and left-parietal stroke: A case study.
29 Jun 1999 - Apraxia in corticobasal degeneration.
29 Jun 1999 - Corticobasal degeneration presenting with progressive spasticity.
4 Mar 2007 - The clinical overlap between the corticobasal degeneration syndrome and other diseases of the frontotemporal spectrum: three case reports.
30 Dec 2006 - Motor neurone disease, dementia and aphasia: coincidence, co-occurrence or continuum?
30 Mar 2001
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a larger map of 100+ related articles.